AzTrials
AzTrials

HIV/AIDSDoDoPiNCT01459120

Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho

A study testing Door-to-door and Pitso in people with HIV/AIDS and Tuberculosis, run by SolidarMed at 2 sites in Lesotho.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this trial is to determine if door-to-door is more effective than community gathering in providing voluntary HIV counseling and testing (VCT) in communities in rural Lesotho. The voluntary HIV counseling and testing will be proposed as an integrated part of a package of proposed services. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
HIV/AIDS, Tuberculosis, Diabetes Mellitus
What is being tested?
Door-to-door and Pitso
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,800 participants
Where
2 sitesLesotho
Study dates
Oct 2011to Feb 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Not already known to be HIV-positive
  • Resident in the catchment area of the health center where the campaign is conducted
  • Provision of written informed consent to participate (signed by writing or fingerprint)
  • In case of children: Provision of written informed consent by an adult care-taker

Who cannot join

None listed.

Trial locations and contacts

2 sites in 1 country.

Lesotho2 sites
  • Seboche Hospital

    Seboche, Botha-Bothe, P.O. 304

  • Paray Hospital

    Thaba-Tseka, Thaba-Tseka

Other trials in Lesotho

About this study

Official title: Comparing Door-to-door Versus Community Gathering in Providing HIV Counseling and Testing Within an Integrated Primary Health Care Package: a Cluster Randomized Trial in Rural Lesotho

The purpose of this trial is to determine if door-to-door is more effective than community gathering in providing voluntary HIV counseling and testing (VCT) in communities in rural Lesotho. The voluntary HIV counseling and testing will be proposed as an integrated part of a package of proposed services. The package consists of: Blood-pressure measurement, blood-glucose measurement, Body-mass-index (adults), weight for height (children), catch-up vaccinations, deworming (children) Vitamin A (children \& young women), family planning for eligible women, Tuberculosis screening and HIV counseling and testing.

Read the detailed description

12 health centers (clusters) in rural Lesotho are matched according to their routine performance in VCT and enrollment into chronic HIV/AIDS care (average numbers tested positive and enrolled into HIV/AIDS care per month per facility). After matching, 6 health centers are randomly assigned to perform door-to-door VCT, whereas the others perform the traditional community gathering approach (called "pitso" in Sesotho). Within the catchment area of each health center five campaigns in five different, randomly selected villages, are held (one day VCT campaign per village). Within each cluster another five villages are randomly selected who do not get a particular campaign and serve as a control for each cluster. In each matched cluster-pair, both health centers conduct the five campaigns during the same week (one conducting it as door-to-door, the other one conducting it through "pitsos" (community gathering)).

Both approaches receive the same resources in terms of finances, time spending doing the VCT-campaign and human resources.

Being tested
Door-to-door, Pitso
Keywords
Home-based HIV-testing, Voluntary Counseling and Testing, Community based testing, HIV/AIDS, Lesotho
Medical subject headings
Acquired Immunodeficiency Syndrome, Tuberculosis, Diabetes Mellitus, Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Door-to-doorOther

    Health workers propose the integrated service package including VCT at the peoples' homes (home-based testing).

  • PitsoOther

    Health care workers propose the integrated service package including VCT through community gatherings ("Pitso").

Study groups in NCT01459120
Study groupRoleWhat they receive
Door-to-DoorExperimentalHealth care workers propose the integrated service package including VCT at the peoples' homes.
Receives: Other: Door-to-door
PitsoActive comparatorHealth care workers propose the integrated service package including VCT through community gatherings ("pitso").
Receives: Other: Pitso
controlNo interventionWithin each cluster (catchment area of a health center), five villages are randomly chosen as comparators on cluster level. These villages get no particular intervention (VCT-campaign). However, routine services continue to be provided. These villages serve as a control for the third primary outcome that assesses the overall numbers newly enrolled into chronic HIV/AIDS care at facility-level.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of newly tested HIV-positive clients over all clients tested for HIV during the campaigns

    Proportion refers to the proportion of newly tested HIV-positive clients among all clients tested for HIV during the voluntary counselling and testing campaigns in each arm.

  2. Proportion of clients newly tested HIV-positive who enrolled into HIV/AIDS care within one month over all clients newly tested HIV-positive during the campaigns

    One month after the campaigns, enrollment of clients who newly tested HIV-positive at the campaign is assessed at the facilities based on the clinics' registers.

    Measured: 4 weeks after tested positive

  3. Overall number newly tested HIV-positive and enrolled into chronic HIV/AIDS-care at each facility

    Between the two study-arms, the overall numbers will be compared in two ways:

    1. Total number positively tested and enrolled into care at the facility during the month after the campaign (this refers to the overall number at facility-level. Irrespective if these patients were tested during one of the campaigns or during routine activities at the facility)
    2. Total number positively tested and enrolled into care from the 5 villages where campaigns were held as compared to the five villages where no campaigns were held.

    Measured: 4 weeks after campaign

  4. Absolute number of newly tested HIV-positive clients

    Refers to the overall number newly tested HIV-positive during the campaigns in both arms

  5. Absolute number of clients newly tested HIV-positive who enrolled into HIV/AIDS care

    This refers to the absolute number newly tested HIV-positive during the campaigns who enrolled thereafter into chronic HIV/AIDS care within one month

    Measured: 4 weeks after tested HIV-positive

Secondary outcomes (10)
  1. CD4-count among clients newly tested HIV-positive

    CD4-counts will be measured on site using a Point-of-care machine.

  2. Clinical WHO-stage among clients newly tested HIV-positive

  3. Proportion of clients screened positive for Tuberculosis during the campaigns

    All clients accessing services (irrespective of HIV-status) will be screened for TB by a nurse. Clients with a positive screening are provided sputum bottles and are entered in the Tuberculosis-suspect register.

  4. Proportion of first-time HIV-testers among all clients accessing the testing services

  5. Proportion of clients with positive tuberculosis screening who return 3 sputum-bottles within ≤ 5 days to the facility

    Tuberculosis-suspect registers and tuberculosis registers at the facility are used for verification

    Measured: 5 days after the campaign was held

  6. Proportion of clients with a positive Tuberculosis-screening who return their sputum-bottles and who have at least one AFB-positive smear.

    Tuberculosis suspect registers and Tuberculosis registers at the facility are used for verification.

    Measured: 5 days after the campaign was held

  7. Demographic characteristics of clients accessing the voluntary counseling and testing services

  8. Absolute number of clients accessing the services at the campaigns who have a positive screening for Tuberculosis

  9. Absolute number of clients with positive tuberculosis screening who return 3 sputum-bottles within ≤ 5 days to the facility

    Measured: ≤ 5 days after the campaigns

  10. Absolute number of clients with a positive Tuberculosis-screening who return their sputum-bottles and who have at least one AFB-positive smear.

    Measured: ≤ 5 days after the campaign

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2011 (estimated)
  2. Study startOct 2011
  3. Primary completionFeb 2012
  4. Study completionFeb 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01459120
Sponsor's protocol ID
DoDoPi-1
Acronym
DoDoPi
Status last verified
Feb 2012
First submitted
18 Oct 2011
Last updated
9 Feb 2012
Results posted
No
Data monitoring committee
No

Publications

  • Labhardt ND, Motlomelo M, Cerutti B, Pfeiffer K, Kamele M, Hobbins MA, Ehmer J. Home-based versus mobile clinic HIV testing and counseling in rural Lesotho: a cluster-randomized trial. PLoS Med. 2014 Dec 16;11(12):e1001768. doi: 10.1371/journal.pmed.1001768. eCollection 2014 Dec.

    PubMed 25513807

Questions about this trial

What is this clinical trial studying?

A study testing Door-to-door and Pitso in people with HIV/AIDS and Tuberculosis, run by SolidarMed at 2 sites in Lesotho.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Lesotho. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of newly tested HIV-positive clients over all clients tested for HIV during the campaigns. The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01459120, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in